Patents/Assignees

Heidelberg Biotech GmbH

2 patents in portfolio

US12571800utility2026
Means and Methods for Treating Angiogenesis-related Diseases
0 cites
US11845784utility2023
Means and Methods for the Treatment of Angiogenesis-, Fibrosis- and Cancer-related Diseases with Protein Oligomers Comprising Nc-1-fc
0 cites